Article Details

WuXi Biologics and Toregem BioPharma to develop antibody for adentia treatment

Retrieved on: 2022-10-12 08:21:38

Tags for this article:

Click the tags to see associated articles and topics

WuXi Biologics and Toregem BioPharma to develop antibody for adentia treatment. View article details on hiswai:

Excerpt

TRG035 is a monoclonal antibody targeting USAG-1 as a tooth regeneration treatment for congenital adentia. Within the partnership, Toregem ...

Article found on: www.labiotech.eu

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up